GlassScriptPhysician profile
Craig W Naugle
NPI 1104805381
$2,049.43
in general payments reported to CMS, 2019-2025
20 companies · $420 in 2025
The $420 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $254 · 2021: $394 · 2022: $152 · 2023: $134 · 2024: $230 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $785.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $591.91 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $214.95 | 2020-2025 | |
| Ucb, INC. | $198.39 | 2019-2025 | Bimzelx |
| Genentech USA, INC. | $173.38 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $163.92 | 2019-2025 | |
| Leo Pharma INC. | $93.99 | 2021-2025 | Adbry |
| Regeneron Healthcare Solutions, INC. | $83.20 | 2019-2025 | Libtayo |
| Lilly USA, LLC | $76.87 | 2019-2025 | Ebglyss, Taltz |
| E.R. Squibb & Sons, L.L.C. | $74.13 | 2023-2025 | Sotyktu |
| Pfizer INC. | $74.05 | 2020-2022 | |
| Incyte Corporation | $70.79 | 2021-2024 | Opzelura |
| Janssen Biotech, INC. | $56.27 | 2021-2025 | Tremfya |
| Fresenius Kabi USA, LLC | $34.55 | 2023-2024 | Idacio |
| Almirall LLC | $33.78 | 2021-2024 | Seysara |
| Mayne Pharma Commercial LLC | $26.88 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $26.51 | 2019-2022 | |
| Organogenesis INC. | $15.74 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $15.33 | 2019 | |
| Merck Sharp & Dohme LLC | $12.85 | 2019 | |
| Strata Skin Sciences, INC. | $11.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Naugle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.